COHANCE

Cohance Lifesciences Ltd., headquartered in Hyderabad, is a global technology-driven Contract Development and Manufacturing Organisation (CDMO) that delivers comprehensive solutions throughout a molecule's lifecycle. Operating in the pharmaceuticals, fine chemicals, and specialty chemicals industries, the company provides services including process research and development, early-stage development, late-stage clinical and commercial manufacturing, and large-scale commercialization. Cohance serves pharmaceutical and specialty chemical companies globally, supplying 19 of the top 20 global innovators and holding a top-three market share in eight of the ten primary active pharmaceutical ingredient (API) molecules. The company leverages specialized technology platforms in Antibody-Drug Conjugates (ADCs) and Oligonucleotides. Its business segments encompass Pharma CDMO, API+, and Specialty Chemicals. Cohance focuses on meeting customer requirements and expectations through its Hyderabad base. No details on founders, key management, subsidiaries, or stock exchange listings are provided.